Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Ketene Activation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel method using phenylketene achieves 68-72% yield without racemization, offering significant cost reduction in pharmaceutical manufacturing for oncology APIs.